Skip to main content
. 2024 Sep 27;19:355. doi: 10.1186/s13023-024-03311-w

Fig. 5.

Fig. 5

Impact of treatment on survival in SPLIS patients with nephropathy. Treatment of SPLIS patients varied: 9 received a kidney transplant (T); 9 only received dialysis (D); 7 only received palliative care (P). It should be noted that one of the patients receiving a transplant also received pyridoxine therapy. Outcomes with dialysis were not significantly better than palliative care (p > 0.05). In contrast, transplanted patients were older at time of last report than those receiving palliative treatment (p = 0.004); Mann Whitney with Bonferroni correction. Median among transplanted cases was 8 years (IQR 7); dialysis 4.4 years (IQR 7.4); palliative care 1.3 years (5.6). Statistically no significant difference was found in age at last report between T and D cases (p > 0.05), although survival trended higher in the T cases compared to D cases